Published in JAMA on June 05, 1996
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol (2003) 2.51
Polio vaccine: is it time for a change? Arch Dis Child (1998) 1.59
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol (2013) 1.44
The risks, costs, and benefits of possible future global policies for managing polioviruses. Am J Public Health (2008) 0.94
Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs. BMC Infect Dis (2015) 0.93
Seroprevalence of Poliovirus Antibodies in the United States Population, 2009-2010. BMC Public Health (2016) 0.84
Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria. J Virol (2015) 0.83
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation. BMC Infect Dis (2016) 0.82
Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China. Clin Vaccine Immunol (2014) 0.81
Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia. J Clin Microbiol (2003) 0.79
Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response. Public Health Rep (2012) 0.78
Community circulation patterns of oral polio vaccine serotypes 1, 2, and 3 after Mexican national immunization weeks. J Infect Dis (2013) 0.77
Seroprevalence of Poliovirus Antibodies in the Kansas City metropolitan area, 2012-2013. Hum Vaccin Immunother (2017) 0.75
Childhood immunizations: position on the enhanced inactivated poliovirus vaccine and live attenuated oral poliovirus vaccine dilemma. J Natl Med Assoc (1997) 0.75
Polio eradication--how near? JAMA (1996) 0.75
Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation. J Vaccines Vaccin (2016) 0.75
Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India. Emerg Infect Dis (2017) 0.75
Bacteriocins of gram-positive bacteria. Bacteriol Rev (1976) 10.66
Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol (1999) 7.79
Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol (1999) 5.08
Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis (2000) 4.82
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol (1999) 4.72
Geographic distribution of wild poliovirus type 1 genotypes. Virology (1987) 4.03
Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol (2000) 3.99
Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA (1985) 3.85
Protease required for processing picornaviral coat protein resides in the viral replicase gene. J Virol (1979) 3.70
Morbidity and mortality associated with the July 1980 heat wave in St Louis and Kansas City, Mo. JAMA (1982) 3.69
Enterovirus 71 infections and neurologic disease--United States, 1977-1991. J Infect Dis (1994) 3.31
Comparison of staphylococcal coagglutination, latex agglutination, and counterimmunoelectrophoresis for bacterial antigen detection. J Clin Microbiol (1979) 3.24
Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res (1995) 2.98
Preparation and characterization of encephalomyocarditis (EMC) virus. Methods Enzymol (1981) 2.81
Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis. N Engl J Med (1995) 2.81
Impact of measurement and feedback on vaccination coverage in public clinics, 1988-1994. JAMA (1997) 2.74
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
Demonstration of a bactericidal substance against beta-hemolytic streptococci in supernatant fluids of staphylococcal cultures. J Bacteriol (1969) 2.62
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res (1991) 2.35
Trial of a supplemental dose of four poliovirus vaccines. N Engl J Med (2000) 2.35
Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res (1992) 2.33
Protein processing map of poliovirus. J Virol (1984) 2.33
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation (1984) 2.33
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation (1997) 2.32
Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet (1993) 2.24
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol (1998) 2.24
Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J Clin Microbiol (1996) 2.23
Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis (1997) 2.16
Rapid identification of beta hemolytic streptococci by counterimmunoelectrophoresis. J Immunol (1973) 2.15
Bactericidal substance from Staphylococcus aureus. Biological properties. J Exp Med (1970) 2.11
Risk factors for outbreaks of influenza in nursing homes. A case-control study. Am J Epidemiol (1986) 1.93
Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus. J Virol (1980) 1.91
Group A streptococcal bacteriocin. Production, purification, and mode of action. J Exp Med (1973) 1.89
Detection of Haemophilus influenzae type b antigens in body fluids, using specific antibody-coated staphylococci. J Clin Microbiol (1977) 1.86
Measles herd immunity. The association of attack rates with immunization rates in preschool children. JAMA (1992) 1.85
Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method. Neurology (2004) 1.83
Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol (1995) 1.83
Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med (1994) 1.79
New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum (1997) 1.78
Picornaviral VPg sequences are contained in the replicase precursor. J Virol (1980) 1.77
Complete sequence of echovirus 23 and its relationship to echovirus 22 and other human enteroviruses. Virus Res (1998) 1.74
The case for global eradication of poliomyelitis. Bull World Health Organ (1987) 1.72
Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol (2000) 1.71
Systemic Haemophilus influenzae disease: an overview. J Pediatr (1979) 1.68
The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol (1989) 1.68
Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation. J Clin Microbiol (1999) 1.62
Molecular phylogeny of all human enterovirus serotypes based on comparison of sequences at the 5' end of the region encoding VP2. Virus Res (1998) 1.61
Bacteriocin of a group B streptococcus: partial purification and characterization. Antimicrob Agents Chemother (1975) 1.59
Kinetic studies on the interaction of bacteriophage type 71 staphylococcal bacteriocin with susceptible bacteria. J Bacteriol (1973) 1.58
Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis (1992) 1.55
Echovirus 22 is an atypical enterovirus. J Virol (1990) 1.55
Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. Int J Epidemiol (2001) 1.53
Viridins, bacteriocins of alpha-hemolytic streptococci: isolation, characterization, and partial purification. Antimicrob Agents Chemother (1976) 1.52
Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil. Emerg Infect Dis (1996) 1.47
Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child. Am J Epidemiol (1984) 1.47
Serotype-specific identification of enterovirus 71 by PCR. J Clin Virol (2000) 1.44
Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes. Antimicrob Agents Chemother (1984) 1.42
Natural history of impetigo. I. Site sequence of acquisition and familial patterns of spread of cutaneous streptococci. J Clin Invest (1972) 1.40
Hematologic abnormalities after oral trimethoprim-sulfamethoxazole therapy in children. Am J Dis Child (1981) 1.40
Evaluation of telephoned computer-generated reminders to improve immunization coverage at inner-city clinics. Public Health Rep (1993) 1.40
Vaccine-associated paralytic poliomyelitis. N Engl J Med (1993) 1.39
Preparing for pandemic influenza: the need for enhanced surveillance. Emerg Infect Dis (1999) 1.32
Risk factors for community- and household-acquired pertussis during a large-scale outbreak in central Wisconsin. J Infect Dis (1988) 1.31
Bacterial etiology of superficial pyoderma in Lebanon. J Pediatr (1968) 1.28
Current poliomyelitis immunization policy in the United States. Pediatr Ann (1990) 1.28
Experimental infection of the skin in the hamster simulating human impetigo. I. Natural history of the infection. J Infect Dis (1970) 1.26
Experimental infection of the skin in the hamster simulating human impetigo. II. Assessment of various therapeutic regimens. Pediatrics (1971) 1.25
Effect of Bactericidal Substance from Staphylococcus aureus on Group A Streptococci II. Structural Alterations. Infect Immun (1970) 1.24
Pneumococci relatively resistant to penicillin: a prevalence survey in children. J Pediatr (1980) 1.22
Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. J Virol Methods (1993) 1.19
Experimental infection of the skin in the hamster simulating human impetigo. III. Interaction between staphylococci and group A streptococci. J Exp Med (1971) 1.17
A randomized controlled trial of influenza vaccine in the elderly. Scientific scrutiny and ethical responsibility. JAMA (1994) 1.17
Echovirus 30 infection and aseptic meningitis in parents of children attending a child care center. J Infect Dis (1994) 1.15
Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy. Pediatr Infect Dis J (1990) 1.14
Use of influenza vaccine in nursing homes. J Am Geriatr Soc (1985) 1.14
Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination. Am J Epidemiol (2001) 1.13
Principles of measles control. Bull World Health Organ (1991) 1.13
The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med (1988) 1.12
Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis. Antimicrob Agents Chemother (1983) 1.11
Purification of a streptococcal bacteriocin (viridin B) and its separation from alpha-hemolysin. Antimicrob Agents Chemother (1979) 1.11
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol (1994) 1.09
The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis (1997) 1.08
Plasmid-mediated production of staphylococcin in bacteriophage type 71 Staphylococcus aureus. Antimicrob Agents Chemother (1974) 1.07
Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol (1998) 1.07
Kawasaki syndrome: association with the application of rug shampoo. Lancet (1982) 1.06
Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team. Pediatrics (1996) 1.06
A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol (1990) 1.05
A randomized trial of the effectiveness of computer-generated telephone messages in increasing immunization visits among preschool children. Arch Pediatr Adolesc Med (1994) 1.04
Oligonucleotide probes for the specific detection of the wild poliovirus types 1 and 3 endemic to Brazil. Intervirology (1991) 1.04
Clinical efficacy of measles vaccine during the 1990 measles epidemic. Pediatr Infect Dis J (1991) 1.04
Report of the task force on children and youth. American Heart Association. Circulation (1993) 1.04
Epidemiologic methods in immunization programs. Epidemiol Rev (1996) 1.03
Ultrastructural and biochemical alterations effected by viridin B, a bacterocin of alpha-hemolytic streptococci. Infect Immun (1976) 1.03
Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt. Bull World Health Organ (1995) 1.03